was read the article
array:24 [ "pii" => "S1807593222024565" "issn" => "18075932" "doi" => "10.1590/S1807-59322010000400010" "estado" => "S300" "fechaPublicacion" => "2010-04-01" "aid" => "20222456" "copyright" => "CLINICS" "copyrightAnyo" => "2010" "documento" => "article" "crossmark" => 0 "licencia" => "https://creativecommons.org/licenses/by-nc/3.0/" "subdocumento" => "fla" "cita" => "Clinics. 2010;65:407-15" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S1807593222024577" "issn" => "18075932" "doi" => "10.1590/S1807-59322010000400011" "estado" => "S300" "fechaPublicacion" => "2010-04-01" "aid" => "20222457" "copyright" => "CLINICS" "documento" => "article" "crossmark" => 0 "licencia" => "https://creativecommons.org/licenses/by-nc/3.0/" "subdocumento" => "fla" "cita" => "Clinics. 2010;65:417-24" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical Sciences</span>" "titulo" => "Assessment of informatization for the dispensing of medications at a university hospital" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "417" "paginaFinal" => "424" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sônia Aparecida Dias Serafim, Aldaisa Cassanho Forster, Maria Jacira Silva Simões, Thais Rodrigues Penaforte" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Sônia Aparecida Dias" "apellidos" => "Serafim" ] 1 => array:2 [ "nombre" => "Aldaisa Cassanho" "apellidos" => "Forster" ] 2 => array:2 [ "nombre" => "Maria Jacira Silva" "apellidos" => "Simões" ] 3 => array:2 [ "nombre" => "Thais Rodrigues" "apellidos" => "Penaforte" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1807593222024577?idApp=UINPBA00004N" "url" => "/18075932/0000006500000004/v1_202212011714/S1807593222024577/v1_202212011714/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1807593222024553" "issn" => "18075932" "doi" => "10.1590/S1807-59322010000400009" "estado" => "S300" "fechaPublicacion" => "2010-04-01" "aid" => "20222455" "copyright" => "CLINICS" "documento" => "article" "crossmark" => 0 "licencia" => "https://creativecommons.org/licenses/by-nc/3.0/" "subdocumento" => "fla" "cita" => "Clinics. 2010;65:401-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical Sciences</span>" "titulo" => "Laparoscopic treatment of Poland’s syndrome using the omentum flap technique" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "401" "paginaFinal" => "406" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "f4-cln_65p401" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 277 "Ancho" => 415 "Tamanyo" => 26184 ] ] "descripcion" => array:1 [ "en" => "<p id="spara40" class="elsevierStyleSimplePara elsevierViewall">The omentum flap on the thoracic wall.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sirlei Santos Costa, Rosa Maria Blotta, Mirandolino Batista Mariano, Luise Meurer, Maria Isabel Albano Edelweiss" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Sirlei Santos" "apellidos" => "Costa" ] 1 => array:2 [ "nombre" => "Rosa Maria" "apellidos" => "Blotta" ] 2 => array:2 [ "nombre" => "Mirandolino Batista" "apellidos" => "Mariano" ] 3 => array:2 [ "nombre" => "Luise" "apellidos" => "Meurer" ] 4 => array:2 [ "nombre" => "Maria Isabel Albano" "apellidos" => "Edelweiss" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1807593222024553?idApp=UINPBA00004N" "url" => "/18075932/0000006500000004/v1_202212011714/S1807593222024553/v1_202212011714/en/main.assets" ] "en" => array:18 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical Sciences</span>" "titulo" => "Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "407" "paginaFinal" => "415" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Rodrigo A. Toledo, Berenice B. Mendonca, Maria Candida B.V. Fragoso, Iberê C. Soares, Madson Q. Almeida, Michelle B. Moraes, Delmar M. Lourenço, Venâncio A.F. Alves, Marcello D. Bronstein, Sergio P.A. Toledo" "autores" => array:10 [ 0 => array:3 [ "nombre" => "Rodrigo A." "apellidos" => "Toledo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "afI-cln_65p407" ] ] ] 1 => array:3 [ "nombre" => "Berenice B." "apellidos" => "Mendonca" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">II</span>" "identificador" => "afII-cln_65p407" ] ] ] 2 => array:3 [ "nombre" => "Maria Candida B.V." "apellidos" => "Fragoso" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">II</span>" "identificador" => "afII-cln_65p407" ] ] ] 3 => array:3 [ "nombre" => "Iberê C." "apellidos" => "Soares" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">III</span>" "identificador" => "afIII-cln_65p407" ] ] ] 4 => array:3 [ "nombre" => "Madson Q." "apellidos" => "Almeida" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">II</span>" "identificador" => "afII-cln_65p407" ] ] ] 5 => array:3 [ "nombre" => "Michelle B." "apellidos" => "Moraes" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "afI-cln_65p407" ] ] ] 6 => array:4 [ "nombre" => "Delmar M." "apellidos" => "Lourenço" "sufijo" => "Jr" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "afI-cln_65p407" ] ] ] 7 => array:3 [ "nombre" => "Venâncio A.F." "apellidos" => "Alves" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">III</span>" "identificador" => "afIII-cln_65p407" ] ] ] 8 => array:4 [ "nombre" => "Marcello D." "apellidos" => "Bronstein" "email" => array:1 [ 0 => "toledorodrigo@usp.br" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">IV</span>" "identificador" => "afIV-cln_65p407" ] ] ] 9 => array:3 [ "nombre" => "Sergio P.A." "apellidos" => "Toledo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "afI-cln_65p407" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Unidade de Endocrinologia Genética, LIM/25 (RAT, MBM, DML, SPAT), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo – São Paulo/SP, Brazil" "etiqueta" => "I" "identificador" => "afI-cln_65p407" ] 1 => array:3 [ "entidad" => "Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular, LIM/42 (BBM, MCBVF, MQA), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo – São Paulo/SP, Brazil" "etiqueta" => "II" "identificador" => "afII-cln_65p407" ] 2 => array:3 [ "entidad" => "Unidade de Patologia Hepática, LIM/14 (ICS, VAA), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo – São Paulo/SP, Brazil" "etiqueta" => "III" "identificador" => "afIII-cln_65p407" ] 3 => array:3 [ "entidad" => "Unidade de Neuroendocrinologia (MDB) da Disciplina de Endocrinologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo – São Paulo/SP, Brazil., Tel: 55 11 3061.7226," "etiqueta" => "IV" "identificador" => "afIV-cln_65p407" ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "f4-cln_65p407" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 430 "Ancho" => 661 "Tamanyo" => 71164 ] ] "descripcion" => array:1 [ "en" => "<p id="spara40" class="elsevierStyleSimplePara elsevierViewall">Maintenance of heterozygosity and positive AIP immunostaining in the B-cell non-Hodgkin lymphoma of the R81X AIP mutated IFS patient.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="cesec10" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle70">INTRODUCTION</span><p id="para10" class="elsevierStylePara elsevierViewall">Acromegaly/gigantism is characterized by excess of growth hormone (GH) largely due to GH-secreting pituitary adenomas.<a class="elsevierStyleCrossRef" href="#bib1">1</a> Although most cases are sporadic, familial forms may occur in association with inherited syndromes such as Multiple Endocrine Neoplasia type 1 (MEN1), Carney complex (CNC), pituitary adenoma predisposition (PAP) and familial isolated pituitary adenoma (FIPA), which includes isolated familial somatotropinoma (IFS).<a class="elsevierStyleCrossRef" href="#bib2">2</a>–<a class="elsevierStyleCrossRef" href="#bib4">4</a></p><p id="para20" class="elsevierStylePara elsevierViewall">Germline mutations and somatic inactivation of the <span class="elsevierStyleItalic">aryl hydrocarbon receptor- interacting protein</span> (<span class="elsevierStyleItalic">AIP</span>) gene have been recently identified in patients with PAP.<a class="elsevierStyleCrossRef" href="#bib2">2</a> The role of <span class="elsevierStyleItalic">AIP</span> in FIPA patients has been confirmed, and more than thirty different <span class="elsevierStyleItalic">AIP</span> inactivating mutations have been identified throughout the gene.<a class="elsevierStyleCrossRef" href="#bib5">5</a> GH-, GH/PRL- and PRL-secreting pituitary adenomas are the most common clinical features of <span class="elsevierStyleItalic">AIP</span> mutation carriers, although ACTH-secreting and non-functioning pituitary adenomas have also been reported.<a class="elsevierStyleCrossRefs" href="#bib5">5,6</a><span class="elsevierStyleItalic">AIP</span> mutations account for approximately 15% of families with FIPA and 50% of IFS families.<a class="elsevierStyleCrossRefs" href="#bib3">3,5</a> While <span class="elsevierStyleItalic">AIP</span> mutations appear to be very rare in cases with sporadic pituitary disease,<a class="elsevierStyleCrossRefs" href="#bib7">7,8,9</a> they are more frequently found in children and adolescents with GH-secreting tumors, even in the absence of family history.<a class="elsevierStyleCrossRef" href="#bib10">10</a></p><p id="para30" class="elsevierStylePara elsevierViewall">Although no systematic clinical surveys of non-pituitary neoplasia have been reported, concomitant non-pituitary tumors, including thyroid, adrenal and MEN1-related tumors were reported in a subset of <span class="elsevierStyleItalic">AIP</span> mutation-positive PAP and FIPA families<a class="elsevierStyleCrossRefs" href="#bib10">10,11</a> and Prof. Albert Beckers, FIPA Meeting, Liège 2009 (unpublished data). The fact that <span class="elsevierStyleItalic">AIP</span> interacts with phosphodiesterases type 4A (PDE4A) and type 2A (PDE2A) implicates this gene in the cyclic AMP (cAMP) signaling cascade,<a class="elsevierStyleCrossRefs" href="#bib12">12,13</a> a cellular pathway known to be disrupted in pituitary, but also in thyroid and adrenal tumorigenesis.<a class="elsevierStyleCrossRefs" href="#bib14">14,15</a> Furthermore, <span class="elsevierStyleItalic">AIP</span> is widely expressed, which may argue in favor of a potential involvement of this gene also in non-pituitary tumors. Thus, one may hypothesize that mutations in <span class="elsevierStyleItalic">AIP</span> may also predispose patients to a broader spectrum of endocrine tumors. However, no genetic investigations of non-pituitary tumors in <span class="elsevierStyleItalic">AIP</span>-mutated patients have been performed to date. In this study, we investigated tumoral samples from a somatotropinoma, an adrenocortical carcinoma and a grade II B-cell non-Hodgkin’s lymphoma from a mother-daughter pair with IFS who harbor a functional <span class="elsevierStyleItalic">AIP</span> germline mutation.</p></span><span id="cesec20" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle80">SUBJECTS</span><p id="para40" class="elsevierStylePara elsevierViewall">We investigated the germline and somatic status of AIP in a previously reported Brazilian family (mother-daughter pair)<a class="elsevierStyleCrossRef" href="#bib16">16</a> with early-onset acromegaly (at 25 years and at 14 years, respectively) due to invasive pituitary macroadenomas who have been followed in our institution for the last decade. This family has been recently included in the ongoing genetic screening program for Multiple Endocrine Neoplasia at the Endocrine Genetics Unit laboratory at the University of São Paulo School of Medicine.<a class="elsevierStyleCrossRef" href="#bib17">17</a>–<a class="elsevierStyleCrossRef" href="#bib24">24</a> Since the initial report of a GH-secreting pituitary adenoma, the index case (mother) subsequently developed a virilizing adrenocortical carcinoma and a grade II B-cell non-Hodgkin lymphoma. Because <span class="elsevierStyleItalic">MEN1</span> and <span class="elsevierStyleItalic">p53</span> mutations had been previously excluded in this case,<a class="elsevierStyleCrossRefs" href="#bib16">16,25</a> we hypothesized that loss of the <span class="elsevierStyleItalic">AIP</span> gene could be implicated.</p></span><span id="cesec30" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle90">CLINICAL FEATURES</span><p id="para50" class="elsevierStylePara elsevierViewall">The index patient was diagnosed with acromegaly due to a pituitary macroadenoma at 25 years of age (1986). MEN1 and CNC syndromes were ruled out given the absence of the characteristic biochemical and clinical features of these syndromes (such as hyperparathyroidism and enteropancreatic tumors for MEN1 and spotty skin pigmentation, cutaneous myxomas and Cushing’s syndrome for CNC). She underwent transsphenoidal surgery followed by radiotherapy and exhibited persistently normal basal serum levels of GH and insulin-like growth factor-1 (IGF-1) after surgery. At present (48 years old), GH and IGF-1 levels remain within the normal range, and the pituitary MRI was normal, indicating that she had been cured of her pituitary disease.</p><p id="para60" class="elsevierStylePara elsevierViewall">Thirteen years after pituitary surgery (1999), she presented with virilization and secondary amenorrhea associated with high serum levels of total testosterone (538 ng/dL; normal range, 15–80 ng/dL) and dehydroepiandrosterone sulfate (DHEA-S) (>10,000 ng/mL; normal range, 350–4300 ng/mL). An abdominal CT scan revealed a large heterogeneous mass (9.0 cm x 8.9 cm) in the right adrenal gland compressing the vena cava and the lower portion of the liver. The tumor was surgically excised <span class="elsevierStyleItalic">en bloc</span> without rupturing the organ capsule through a classic lobotomy, and right nephrectomy and extensive resection of local lymph nodes were performed. The histopathological analysis ruled out the invasion of local lymph nodes, liver or vena cava, and the tumor was staged as MacFarlane-II and Weiss-III (high nuclear grade, absence of clear cells and diffuse architecture), indicating adrenocortical carcinoma. There has been no biochemical or imaging evidence of tumor recurrence during 10 years of post-surgical follow-up (1999–2009).</p><p id="para70" class="elsevierStylePara elsevierViewall">At the age of 42 (2001), the patient developed an apparently indolent grade 2 (WHO classification) slow-growing follicular B-cell non-Hodgkin lymphoma. The immunophenotype was ascertained by immunohistochemical studies of lymph node biopsy samples. The samples were positive for anti-BCL-2, CD10, CD20 and CD68 antibodies and negative for CD3 (in the follicles).</p><p id="para80" class="elsevierStylePara elsevierViewall">The patient also presented two solid thyroid nodules of 7 mm and 11 mm in size, without adenomegaly, that had been identified in previous cervical ultrasonograms (1999). Pelvic imaging studies (2001) showed ovaries of 5.1 cm and 7.8 cm, respectively, two ovarian cysts (4.7 cm and 5.5 cm) and periaortic, cava-aortic and iliac lymph nodes that were enlarged by up to 2 cm. She underwent a hysterectomy due to adenomyosis and an oophorectomy (right ovary) due to enlarged follicle cysts.</p><span id="cesec40" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle100">Family history</span><p id="para90" class="elsevierStylePara elsevierViewall">The index patient has two daughters (dizygotic twins) and one son (<a class="elsevierStyleCrossRef" href="#f1-cln_65p407">Figure 1A</a>). One of the female twins was evaluated at 14 years of age. She was 167 cm tall and presented with mild acromegaloid features but no signs of gigantism. The GH and IGF-1 serum levels were high, whereas prolactin was normal. An MRI revealed a large pituitary adenoma with suprasellar extension, as well as an invasion of the cavernous and sphenoid sinuses. The tumor was resistant to somatostatin analog therapy. The patient subsequently underwent two transcranial surgeries, one of which involved a transcavernous approach. Histopathological immunohistochemistry analyses indicated that the pituitary adenoma was positive for GH. No clinical and biochemical features of the MEN1 and CNC syndromes were observed in this patient. She has been followed up periodically since 2000, and any adrenal involvement has been ruled out by clinical assessment, determination of adrenal steroid levels and imaging studies (abdominal CT scans). The other female twin and the son were clinically and biochemically normal.</p><elsevierMultimedia ident="f1-cln_65p407"></elsevierMultimedia><p id="para100" class="elsevierStylePara elsevierViewall">The index patient reported that one of her sisters also exhibited thyroid nodules and that her mother and another sister had ovarian cysts. These individuals were not available for clinical assessment.</p></span></span><span id="cesec50" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle110">GENETIC (NON-<span class="elsevierStyleItalic">AIP</span>) FEATURES</span><span id="cesec60" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle120"><span class="elsevierStyleItalic">MEN1</span> gene</span><p id="para110" class="elsevierStylePara elsevierViewall">As previously reported, the index patient did not harbor a germline <span class="elsevierStyleItalic">MEN1</span> mutation; however, she and her acromegalic daughter share 13 microsatellite loci at chromosomal region 11q13.<a class="elsevierStyleCrossRef" href="#bib16">16</a></p></span><span id="cesec70" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle130"><span class="elsevierStyleItalic">P53</span> gene</span><p id="para120" class="elsevierStylePara elsevierViewall">Furthermore, the index patient did not have a germline or somatic R337H <span class="elsevierStyleItalic">TP53</span> mutation, which is commonly identified in children but less frequently identified in adult patients with adrenocortical neoplasia in southern Brazil.<a class="elsevierStyleCrossRef" href="#bib25">25</a></p></span></span><span id="cesec80" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle140">TUMORS</span><p id="para130" class="elsevierStylePara elsevierViewall">Both paraffin blocks and frozen tissue samples of the daughter’s GH-secreting pituitary adenoma and the mother’s adrenocortical tumor and B-cell non-Hodgkin lymphoma were available for study. Samples from the thyroid and ovarian tissues and the mother’s somatotropinoma were not available.</p></span><span id="cesec90" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle150">METHODS</span><p id="para140" class="elsevierStylePara elsevierViewall">The present study was approved by the local ethics committee (Cappesq) of our institution (protocol 0437/08). All patients and control subjects gave written informed consent.</p><span id="cesec100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle160"><span class="elsevierStyleItalic">AIP</span> germline mutation analysis</span><p id="para150" class="elsevierStylePara elsevierViewall">Genomic DNA was isolated from the peripheral blood using a standard salting-out protocol, and PCR reactions were performed as previously described.<a class="elsevierStyleCrossRef" href="#bib2">2</a> Both DNA strands were sequenced from purified PCR products using Big Dye Terminator v3.1 (Applied Biosystems, Foster City, CA) and an automated sequencer (ABI Prism 3130xl DNA Analyser, Applied Biosystems).</p></span><span id="cesec110" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle170">Loss-of-heterozygosity analysis</span><p id="para160" class="elsevierStylePara elsevierViewall">Two different approaches (intragenic and extragenic) were used to verify whether the <span class="elsevierStyleItalic">AIP</span> wild-type allele was lost in the tumors. The mother’s somatotropinoma and thyroid neoplasm were not available for study. We performed PCR amplification, automated sequencing and haplotyping analysis using the D11S1258-11q13 microsatellite marker located close (67,069,747–67,069,958 bp, Ensembl) to the <span class="elsevierStyleItalic">AIP</span> gene 11q13.3 locus (67,007,097–67,015,150 bp, Ensembl).</p></span><span id="cesec120" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle180">Quantitative mRNA analysis</span><p id="para170" class="elsevierStylePara elsevierViewall">A commercially available RNA/cDNA pool of normal adrenals (n=61), normal pituitary and normal adrenal tissues obtained from autopsies (Clontech, Palo Alto, CA) were used as controls. Quantitative PCR (qPCR) was performed with an ABI Prism 7700 Sequence Detector using the TaqMan Gene Expression Assays (Hs00610222_m1 for AIP and 43263 for β-actin) following the manufacturer’s instructions (Applied Biosystems). A cycle threshold (CT) value in the linear range of amplification was selected for each sample in triplicate and normalized to the β<span class="elsevierStyleItalic">-actin</span> expression levels. The relative expression levels were analyzed using the 2<span class="elsevierStyleSup">-δ δ</span>CT method,<a class="elsevierStyleCrossRef" href="#bib26">26</a> where δ δCT is the difference between the selected δCT value of a particular sample and the δCT of a pool of normal adrenals.</p></span><span id="cesec130" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle190">AIP immunohistochemistry</span><p id="para180" class="elsevierStylePara elsevierViewall">The slides were deparaffinized, hydrated and subsequently incubated in a 10 mM citrate buffer (pH 6.0) on a steamer for 40 min at 95 ºC. After several washes, each set of slides was incubated overnight with an anti-ARA9/ AIP monoclonal primary antibody (clone 35-2, Novus Biologicals, Littleton, CO), and then with the Novolink (Vision Biosystems™, Victoria, Au) secondary peroxidase short polymer system. Detailed information on qPCR and immunohistochemistry protocols can be obtained upon request.</p></span></span><span id="cesec140" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle200">RESULTS</span><span id="cesec150" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle210"><span class="elsevierStyleItalic">AIP</span> germline status in the IFS patients</span><p id="para190" class="elsevierStylePara elsevierViewall">A heterozygous nucleotide change c.241C>T (R81X) in exon 2 of <span class="elsevierStyleItalic">AIP</span> was identified in genomic DNA samples from the two acromegaly patients (mother and daughter) (<a class="elsevierStyleCrossRef" href="#f1-cln_65p407">Figure 1</a>). The R81X is a known functional mutation that codes for a truncated protein lacking the tetratricopeptide repeat (TPR) carboxy terminal domains, which are essential for AIP to bind to the aryl hydrocarbon receptor (AHR) and heat shock 90 (HSP90).<a class="elsevierStyleCrossRefs" href="#bib12">12,27</a> Previous <span class="elsevierStyleItalic">in vitro</span> studies of the R81X mutation have shown that it blocks the interaction of wild type AIP and phosphodiesterase type 4A (PDE4A), potentially disrupting the cAMP cascade.<a class="elsevierStyleCrossRef" href="#bib28">28</a></p></span><span id="cesec160" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle220"><span class="elsevierStyleItalic">AIP</span> somatic status in the somatotropinoma, adrenocortical tumor and B-cell non-Hodgkin lymphoma</span><p id="para200" class="elsevierStylePara elsevierViewall">Sequencing the <span class="elsevierStyleItalic">AIP</span> gene in the tumoral DNA samples revealed a complete loss of the remaining wild-type allele “C” in both the pituitary and adrenocortical tumors (<a class="elsevierStyleCrossRef" href="#f2-cln_65p407">Figures 2B</a>, <a class="elsevierStyleCrossRef" href="#f3-cln_65p407">3B</a>). Samples from the adrenocortical tumor and B-cell non-Hodgkin lymphoma were analyzed with the <span class="elsevierStyleItalic">AIP</span>-flanking microsatellite marker D11S1258, and LOH was confirmed in the adrenocortical tumor (<a class="elsevierStyleCrossRef" href="#f3-cln_65p407">Figure 3B</a>). However, the lymphoma maintained heterozygosity at the <span class="elsevierStyleItalic">AIP</span> locus (<a class="elsevierStyleCrossRef" href="#f4-cln_65p407">Figure 4</a>).</p><elsevierMultimedia ident="f2-cln_65p407"></elsevierMultimedia><elsevierMultimedia ident="f3-cln_65p407"></elsevierMultimedia><elsevierMultimedia ident="f4-cln_65p407"></elsevierMultimedia></span><span id="cesec170" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle230"><span class="elsevierStyleItalic">AIP</span> gene expression in normal adrenals and the adrenocortical tumor of the IFS <span class="elsevierStyleItalic">AIP</span>-mutated patient</span><p id="para210" class="elsevierStylePara elsevierViewall">The mean Ct values of <span class="elsevierStyleItalic">AIP</span> and β<span class="elsevierStyleItalic">-actin</span> in the pool of normal adrenal samples were 25.42 and 22.49, respectively, while in the adrenocortical carcinoma of the IFS <span class="elsevierStyleItalic">AIP</span>-mutated case, the values were 31.53 and 27.28, respectively. Using the 2<span class="elsevierStyleSup">-δ δ</span>CT method to determine relative expression, we observed decreased <span class="elsevierStyleItalic">AIP</span> expression in the adrenocortical carcinoma in comparison to the pooled normal adrenals (2<span class="elsevierStyleSup">-δ δ</span>CT = 0.48) (<a class="elsevierStyleCrossRef" href="#f3-cln_65p407">Figure 3C</a>). This finding is in accordance with our analysis of the somatic status of <span class="elsevierStyleItalic">AIP,</span> which showed LOH in this non-pituitary (adrenocortical) tumor, as shown in <a class="elsevierStyleCrossRef" href="#f3-cln_65p407">Figure 3B</a>.</p></span><span id="cesec180" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle240">AIP immunohistochemistry</span><span id="cesec190" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle250">Pituitary tissue</span><p id="para220" class="elsevierStylePara elsevierViewall">Decreased AIP immunostaining was observed in the pituitary adenoma from the daughter harboring the R81X germline mutation, while intense cytoplasmic AIP positivity was observed in the normal pituitary glands obtained from autopsy samples and in a somatotropinoma from a patient with sporadic acromegaly without the <span class="elsevierStyleItalic">AIP</span> germline mutation (<a class="elsevierStyleCrossRef" href="#f2-cln_65p407">Figure 2C</a>).</p></span><span id="cesec200" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle260">Adrenal tissue</span><p id="para230" class="elsevierStylePara elsevierViewall">The mother’s adrenocortical carcinoma showed positive staining for Melan A and 35betaH11 (data not shown), which are two markers of adrenal cortical differentiation used as positive controls, and complete loss of AIP immunoreactivity (<a class="elsevierStyleCrossRef" href="#f3-cln_65p407">Figure 3D</a>). Moderate and strong staining of AIP-positive cells was observed in normal adult (<a class="elsevierStyleCrossRef" href="#f3-cln_65p407">Figure 3D</a>) and infant adrenal tissue, respectively.</p></span><span id="cesec210" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle270">Grade II B-cell non-Hodgkin lymphoma</span><p id="para240" class="elsevierStylePara elsevierViewall">Normal AIP protein expression was observed in the index patient’s B-cell lymphoma when compared to the amygdala lymphoid tissue, which was used as a control (<a class="elsevierStyleCrossRef" href="#f4-cln_65p407">Figure 4</a>).</p></span></span></span><span id="cesec220" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle280">DISCUSSION</span><p id="para250" class="elsevierStylePara elsevierViewall">Rare extra-pituitary tumors have been identified in PAP/ FIPA patients harboring <span class="elsevierStyleItalic">AIP</span> mutations. Mutant AIP cannot interact with cAMP-specific PDE4A and therefore is likely to disrupt the cAMP signaling pathway.<a class="elsevierStyleCrossRefs" href="#bib12">12,27,28</a> This pathway has been previously implicated in both pituitary and non-pituitary tumorigenesis through defects in the <span class="elsevierStyleItalic">PRKAR1A,</span><a class="elsevierStyleCrossRef" href="#bib29">29</a><span class="elsevierStyleItalic">GNAS1,</span><a class="elsevierStyleCrossRef" href="#bib30">30</a><span class="elsevierStyleItalic">PDE11A</span><a class="elsevierStyleCrossRef" href="#bib31">31</a> and <span class="elsevierStyleItalic">PDE8B</span><a class="elsevierStyleCrossRef" href="#bib32">32</a> genes. Thus, further investigation of the role of <span class="elsevierStyleItalic">AIP</span> in these concomitant non-pituitary tumors is warranted. Here, we present the first somatic investigations of pituitary and non-pituitary tumors (somatotropinoma, adrenocortical and grade II B-cell non-Hodgkin lymphoma) in a family harboring an <span class="elsevierStyleItalic">AIP</span> germline mutation.</p><p id="para260" class="elsevierStylePara elsevierViewall">We initially found that both the mother and daughter with acromegaly harbored a functional cAMP pathway-disrupting germline mutation in <span class="elsevierStyleItalic">AIP</span> (c.241C>T; R81X). Through sequence analysis of tumoral samples, we showed that the remaining wild-type allele C was lost in the daughter’s GH-secreting pituitary adenoma and the mother’s adrenocortical carcinoma. LOH was confirmed by analyzing the D11S1258 repeat marker located at the <span class="elsevierStyleItalic">AIP</span> locus (11q13.3). In addition, we observed decreased AIP mRNA and protein expression in the adrenocortical tissue when compared to normal controls (<a class="elsevierStyleCrossRef" href="#f3-cln_65p407">Figure 3C and 3D</a>). In contrast, normal AIP protein expression and no LOH for 11q13.3 locus were verified in the B-cell non-Hodgkin lymphoma from the same patient (<a class="elsevierStyleCrossRef" href="#f4-cln_65p407">Figure 4</a>). According to the Knudson two-hit model, these findings confirm that <span class="elsevierStyleItalic">AIP</span> plays a tumor suppressor role in the pituitary, as previously reported,<a class="elsevierStyleCrossRefs" href="#bib2">2,3,4,8</a> and suggest for the first time that <span class="elsevierStyleItalic">AIP</span> may also be implicated in non-pituitary tumorigenesis. Interestingly, previous genetic studies have strongly suggested the existence of an as-yet-unidentified tumor suppressor gene at 11q13 that is implicated in adrenocortical tumorigenesis.<a class="elsevierStyleCrossRef" href="#bib33">33</a>–<a class="elsevierStyleCrossRef" href="#bib35">35</a> We are expanding the analysis of <span class="elsevierStyleItalic">AIP</span> to a large cohort of Brazilian sporadic adrenocortical tumors.</p><p id="para270" class="elsevierStylePara elsevierViewall">Of note, a reported female patient harboring a germline nonsense <span class="elsevierStyleItalic">AIP</span> mutation, L210X, developed a broad panel of neoplasias involving the pituitary, adrenocortical and thyroid glands;<a class="elsevierStyleCrossRef" href="#bib10">10</a> this previous report suggests that the tumor susceptibility was similar to that observed in our index case. The L201X-mutated patient presented with secondary amenorrhea at the age of 25 and was diagnosed with acromegaly at 27 years of age. Subsequently, she developed a 19-mm non-secretory adrenocortical adenoma and a 4-cm thyroid adenoma. Georgitsi <span class="elsevierStyleItalic">et al.</span> studied 91 cases of “MEN1-related” tumors without <span class="elsevierStyleItalic">MEN1</span> mutation, and they detected 2 cases (2.2 %) with <span class="elsevierStyleItalic">AIP</span> germline mutations.<a class="elsevierStyleCrossRef" href="#bib11">11</a> However, no details of the clinical manifestation of the mutated patients were provided, and it is not clear if they were FIPA/IFS patients. Recently, patients with <span class="elsevierStyleItalic">AIP</span> mutations and thyroid disorders, including nodular goiters, follicular adenomas and follicular and papillary thyroid carcinomas, have been described (Prof. Beckers, FIPA Workshop 2009, Liège, unpublished data; Drs. Outi Vierimaa and Pasi Salmela, University of Helsinki, Marianthi Georgitsi’s PhD Thesis). In these cases, it is not known whether the non-pituitary tumors occurring in the FIPA cases harboring an <span class="elsevierStyleItalic">AIP</span> mutation were related to the primary germline event. Further molecular investigations in FIPA/IFS patients with non-pituitary tumors would improve our knowledge of the tumoral susceptibility caused by <span class="elsevierStyleItalic">AIP</span> germline defects.</p><p id="para280" class="elsevierStylePara elsevierViewall">In conclusion, our study presents the first molecular analysis of non-pituitary tumors in patients harboring the <span class="elsevierStyleItalic">AIP</span> germline mutation. The finding of somatic <span class="elsevierStyleItalic">AIP</span> inactivation in the adrenocortical tumor of a <span class="elsevierStyleItalic">AIP</span>-mutated patient suggests that we should further investigate the role of this recently identified tumor suppressor gene in non-pituitary tumors, especially those tumors in which cAMP and the 11q13 locus are implicated.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:2 [ "identificador" => "xpalclavsec1582848" "titulo" => "KEYWORDS:" ] 1 => array:2 [ "identificador" => "cesec10" "titulo" => "INTRODUCTION" ] 2 => array:2 [ "identificador" => "cesec20" "titulo" => "SUBJECTS" ] 3 => array:3 [ "identificador" => "cesec30" "titulo" => "CLINICAL FEATURES" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "cesec40" "titulo" => "Family history" ] ] ] 4 => array:3 [ "identificador" => "cesec50" "titulo" => "GENETIC (NON-AIP) FEATURES" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "cesec60" "titulo" => "MEN1 gene" ] 1 => array:2 [ "identificador" => "cesec70" "titulo" => "P53 gene" ] ] ] 5 => array:2 [ "identificador" => "cesec80" "titulo" => "TUMORS" ] 6 => array:3 [ "identificador" => "cesec90" "titulo" => "METHODS" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "cesec100" "titulo" => "AIP germline mutation analysis" ] 1 => array:2 [ "identificador" => "cesec110" "titulo" => "Loss-of-heterozygosity analysis" ] 2 => array:2 [ "identificador" => "cesec120" "titulo" => "Quantitative mRNA analysis" ] 3 => array:2 [ "identificador" => "cesec130" "titulo" => "AIP immunohistochemistry" ] ] ] 7 => array:3 [ "identificador" => "cesec140" "titulo" => "RESULTS" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "cesec150" "titulo" => "AIP germline status in the IFS patients" ] 1 => array:2 [ "identificador" => "cesec160" "titulo" => "AIP somatic status in the somatotropinoma, adrenocortical tumor and B-cell non-Hodgkin lymphoma" ] 2 => array:2 [ "identificador" => "cesec170" "titulo" => "AIP gene expression in normal adrenals and the adrenocortical tumor of the IFS AIP-mutated patient" ] 3 => array:3 [ "identificador" => "cesec180" "titulo" => "AIP immunohistochemistry" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "cesec190" "titulo" => "Pituitary tissue" ] 1 => array:2 [ "identificador" => "cesec200" "titulo" => "Adrenal tissue" ] 2 => array:2 [ "identificador" => "cesec210" "titulo" => "Grade II B-cell non-Hodgkin lymphoma" ] ] ] ] ] 8 => array:2 [ "identificador" => "cesec220" "titulo" => "DISCUSSION" ] 9 => array:1 [ "titulo" => "REFERENCES" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2010-03-22" "fechaAceptado" => "2010-03-25" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "KEYWORDS:" "identificador" => "xpalclavsec1582848" "palabras" => array:5 [ 0 => "Acromegaly" 1 => "pituitary tumor" 2 => "FIPA" 3 => "AIP" 4 => "Adrenocortical tumor" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "resumen" => "<span id="ceabs10" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle10">OBJECTIVE</span><p id="spara50" class="elsevierStyleSimplePara elsevierViewall">Non-pituitary tumors have been reported in a subset of patients harboring germline mutations in the <span class="elsevierStyleItalic">aryl hydrocarbon receptor-interacting protein</span> (<span class="elsevierStyleItalic">AIP</span>) gene. However, no detailed investigations of non-pituitary tumors of <span class="elsevierStyleItalic">AIP</span>-mutated patients have been reported so far.</p></span> <span id="ceabs20" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle20">PATIENTS</span><p id="spara60" class="elsevierStyleSimplePara elsevierViewall">We examined a <span class="elsevierStyleItalic">MEN1</span>- and <span class="elsevierStyleItalic">p53</span>-negative mother-daughter pair with acromegaly due to somatotropinoma. Subsequently, the mother developed a large virilizing adrenocortical carcinoma and a grade II B-cell non-Hodgkin’s lymphoma.</p></span> <span id="ceabs30" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle30">DESIGN</span><p id="spara70" class="elsevierStyleSimplePara elsevierViewall">Mutational analysis was performed by automated sequencing. Loss-of-heterozygosity (LOH) analysis was carried out by sequencing and microsatellite analysis. AIP expression was assessed through quantitative PCR (qPCR) and immunohistochemistry.</p></span> <span id="ceabs40" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle40">RESULTS</span><p id="spara80" class="elsevierStyleSimplePara elsevierViewall">The functional inactivating mutation c.241C>T (R81X), which blocks the AIP protein from interacting with phosphodiesterase 4A (PDE4A), was identified in the heterozygous state in the leukocyte DNA of both patients. Analyzing the tumoral DNA revealed that the <span class="elsevierStyleItalic">AIP</span> wild-type allele was lost in the daughter’s somatotropinoma and the mother’s adrenocortical carcinoma. Both tumors displayed low AIP protein expression levels. Low <span class="elsevierStyleItalic">AIP</span> gene expression was confirmed by qPCR in the adrenocortical carcinoma. No evidence of LOH was observed in the DNA sample from the mother’s B-cell lymphoma, and this tumor displayed normal AIP immunostaining.</p></span> <span id="ceabs50" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle50">CONCLUSIONS</span><p id="spara90" class="elsevierStyleSimplePara elsevierViewall">Our study presents the first molecular analysis of non-pituitary tumors in <span class="elsevierStyleItalic">AIP</span>-mutated patients. The finding of <span class="elsevierStyleItalic">AIP</span> inactivation in the adrenocortical tumor suggests that further investigation of the potential role of this recently identified tumor suppressor gene in non-pituitary tumors, mainly in those tumors in which the cAMP and the 11q13 locus are implicated, is likely to be worthwhile.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "ceabs10" "titulo" => "OBJECTIVE" ] 1 => array:2 [ "identificador" => "ceabs20" "titulo" => "PATIENTS" ] 2 => array:2 [ "identificador" => "ceabs30" "titulo" => "DESIGN" ] 3 => array:2 [ "identificador" => "ceabs40" "titulo" => "RESULTS" ] 4 => array:2 [ "identificador" => "ceabs50" "titulo" => "CONCLUSIONS" ] ] ] ] "multimedia" => array:4 [ 0 => array:7 [ "identificador" => "f1-cln_65p407" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 627 "Ancho" => 560 "Tamanyo" => 52657 ] ] "descripcion" => array:1 [ "en" => "<p id="spara10" class="elsevierStyleSimplePara elsevierViewall">Genealogy: identification of a functional <span class="elsevierStyleItalic">AIP</span> mutation that may disrupt the cAMP signaling pathway. <span class="elsevierStyleBold">A -</span> The index patient developed acromegaly, adrenocortical carcinoma and B-cell lymphoma. One of her daughters had acromegaly due to a large and invasive somatotropinoma. <span class="elsevierStyleBold">B -</span> The known <span class="elsevierStyleItalic">AIP</span> functional mutation c.241C>T (R81X)<a class="elsevierStyleCrossRef" href="#bib28">28</a> was identified in genomic DNA samples from both patients (mother and daughter) with acromegaly but not in the three unaffected family members.</p>" ] ] 1 => array:7 [ "identificador" => "f2-cln_65p407" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 514 "Ancho" => 600 "Tamanyo" => 92726 ] ] "descripcion" => array:1 [ "en" => "<p id="spara20" class="elsevierStyleSimplePara elsevierViewall">Loss of <span class="elsevierStyleItalic">AIP</span> in the familial somatotropinoma. <span class="elsevierStyleBold">A -</span> The MRI of the index patient’s daughter revealed a large and invasive pituitary adenoma (so-matotropinoma) that was resistant to treatment with a somatostatin analog. She inherited the heterozygous R81X <span class="elsevierStyleItalic">AIP</span> germline mutation (<a class="elsevierStyleCrossRef" href="#f1-cln_65p407">Fig. 1B</a>) from the index case. <span class="elsevierStyleBold">B -</span> The sequence analysis of <span class="elsevierStyleItalic">AIP</span> in tumoral DNA samples revealed that only the R81X-mutated allele (t) was present in the somatotropinoma, indicating somatic loss and inactivation of wild-type <span class="elsevierStyleItalic">AIP</span>. <span class="elsevierStyleBold">C -</span> The immunohistochemical analysis showed AIP protein expression in the normal pituitary and a GH-secreting pituitary adenoma of a patient with sporadic acromegaly without <span class="elsevierStyleItalic">AIP</span> mutation. The somatotropinoma of the patient harboring the R81X germline mutation and the somatic loss of the gene presented low AIP protein expression.</p>" ] ] 2 => array:7 [ "identificador" => "f3-cln_65p407" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 533 "Ancho" => 603 "Tamanyo" => 75494 ] ] "descripcion" => array:1 [ "en" => "<p id="spara30" class="elsevierStyleSimplePara elsevierViewall">Loss of <span class="elsevierStyleItalic">AIP</span> in the adrenocortical tumor. <span class="elsevierStyleBold">A -</span> An abdominal imaging scan of the index case when she presented with virilization and high serum levels of adrenal steroids. The scan revealed a large heterogeneous mass (9.0 cm x 8.9 cm) in the right adrenal gland, which was surgically excised and histopathologically classified as adrenocortical carcinoma. <span class="elsevierStyleBold">B -</span> Sequence and microsatellite (D11S1258 <span class="elsevierStyleItalic">AIP</span>-flanking marker) analyses of DNA samples from the tumor revealed loss of the wild-type <span class="elsevierStyleItalic">AIP</span> allele. <span class="elsevierStyleBold">C -</span> The 2<span class="elsevierStyleSup">-δ δ</span> CT method was used to compare <span class="elsevierStyleItalic">AIP</span> mRNA expression in pooled normal pituitary glands (Ct AIP=25.66, Ct β-actin=24.24), pooled normal adrenal glands (Ct AIP=25.42; Ct β-actin=22.49) and the adrenocortical carcinoma from the index case, in whom the <span class="elsevierStyleItalic">AIP</span> wild-type allele was lost (Ct AIP=31.53, Ct β-actin=27.28). The mean Ct value of the normal adrenal pool was used as a reference (1.0), by comparison, there was decreased <span class="elsevierStyleItalic">AIP</span> expression in the adrenocortical carcinoma (0.48). <span class="elsevierStyleBold">D -</span> Immunohistochemistry using the AIP antibody showed low/ moderate staining in a normal adrenal gland obtained from autopsy. A complete loss of AIP immunoreactivity was observed in the adrenocortical carcinoma from the index patient, which stained positive for Melan A and 35betaH11, which were used as positive controls.</p>" ] ] 3 => array:7 [ "identificador" => "f4-cln_65p407" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 430 "Ancho" => 661 "Tamanyo" => 71164 ] ] "descripcion" => array:1 [ "en" => "<p id="spara40" class="elsevierStyleSimplePara elsevierViewall">Maintenance of heterozygosity and positive AIP immunostaining in the B-cell non-Hodgkin lymphoma of the R81X AIP mutated IFS patient.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "REFERENCES" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "cebibsec10" "bibliografiaReferencia" => array:35 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Medical progress: acromegaly" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => """ S Melmed \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMra062453" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2006" "volumen" => "355" "paginaInicial" => "2558" "paginaFinal" => "2573" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17167139" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary adenoma predisposition caused by germline mutations in the AIP gene" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ O Vierimaa \n \t\t\t\t\t\t\t\t """ 1 => """ M Georgitsi \n \t\t\t\t\t\t\t\t """ 2 => """ R Lehtonen \n \t\t\t\t\t\t\t\t """ 3 => """ P Vahteristo \n \t\t\t\t\t\t\t\t """ 4 => """ A Kokko \n \t\t\t\t\t\t\t\t """ 5 => """ A Raitila \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.1126100" "Revista" => array:6 [ "tituloSerie" => "Science" "fecha" => "2006" "volumen" => "312" "paginaInicial" => "1228" "paginaFinal" => "1230" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16728643" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ AF Daly \n \t\t\t\t\t\t\t\t """ 1 => """ JF Vanbellinghen \n \t\t\t\t\t\t\t\t """ 2 => """ SK Khoo \n \t\t\t\t\t\t\t\t """ 3 => """ ML Jaffrain-Rea \n \t\t\t\t\t\t\t\t """ 4 => """ LA Naves \n \t\t\t\t\t\t\t\t """ 5 => """ MA Guitelman \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2006-2513" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2007" "volumen" => "92" "paginaInicial" => "1891" "paginaFinal" => "1896" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17244780" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Isolated familial somatotropinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => """ BS Soares \n \t\t\t\t\t\t\t\t """ 1 => """ LA Frohman \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11102-005-0-04-0" "Revista" => array:6 [ "tituloSerie" => "Pituitary" "fecha" => "2004" "volumen" => "7" "paginaInicial" => "95" "paginaFinal" => "101" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15761658" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genetic, molecular and clinical features of familial isolated pituitary adenomas" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => """ AF Daly \n \t\t\t\t\t\t\t\t """ 1 => """ MA Tichomirowa \n \t\t\t\t\t\t\t\t """ 2 => """ A Beckers \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000192448" "Revista" => array:6 [ "tituloSerie" => "Horm Res" "fecha" => "2009" "volumen" => "71" "paginaInicial" => "116" "paginaFinal" => "122" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19407507" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ RA Toledo \n \t\t\t\t\t\t\t\t """ 1 => """ DM Lourenco Jr \n \t\t\t\t\t\t\t\t """ 2 => """ B Liberman \n \t\t\t\t\t\t\t\t """ 3 => """ MB Cunha-Neto \n \t\t\t\t\t\t\t\t """ 4 => """ MG Cavalcanti \n \t\t\t\t\t\t\t\t """ 5 => """ CB Moyses \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2006-2394" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2007" "volumen" => "92" "paginaInicial" => "1934" "paginaFinal" => "1937" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17341560" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ A Barlier \n \t\t\t\t\t\t\t\t """ 1 => """ JF Vanbellinghen \n \t\t\t\t\t\t\t\t """ 2 => """ AF Daly \n \t\t\t\t\t\t\t\t """ 3 => """ M Silvy \n \t\t\t\t\t\t\t\t """ 4 => """ ML Jaffrain-Rea \n \t\t\t\t\t\t\t\t """ 5 => """ J Trouillas \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2006-2702" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2007" "volumen" => "92" "paginaInicial" => "1952" "paginaFinal" => "1955" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17299063" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => """ T Iwata \n \t\t\t\t\t\t\t\t """ 1 => """ S Yamada \n \t\t\t\t\t\t\t\t """ 2 => """ N Mizusawa \n \t\t\t\t\t\t\t\t """ 3 => """ HM Golam \n \t\t\t\t\t\t\t\t """ 4 => """ T Sano \n \t\t\t\t\t\t\t\t """ 5 => """ K Yoshimoto \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Endocrinol" "fecha" => "2007" "volumen" => "66" "paginaInicial" => "99" "paginaFinal" => "502" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ S Igreja \n \t\t\t\t\t\t\t\t """ 1 => """ HS Chahal \n \t\t\t\t\t\t\t\t """ 2 => """ SA Akker \n \t\t\t\t\t\t\t\t """ 3 => """ M Gueorguiev \n \t\t\t\t\t\t\t\t """ 4 => """ V Popovic \n \t\t\t\t\t\t\t\t """ 5 => """ S Damjanovic \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Endocrinol" "fecha" => "2009" "volumen" => "70" "paginaInicial" => "259" "paginaFinal" => "264" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ L Cazabat \n \t\t\t\t\t\t\t\t """ 1 => """ R Libe \n \t\t\t\t\t\t\t\t """ 2 => """ K Perlemoine \n \t\t\t\t\t\t\t\t """ 3 => """ F Rene-Corail \n \t\t\t\t\t\t\t\t """ 4 => """ N Burnichon \n \t\t\t\t\t\t\t\t """ 5 => """ AP Gimenez-Roqueplo \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1530/EJE-07-0181" "Revista" => array:6 [ "tituloSerie" => "Eur J Endocrinol" "fecha" => "2007" "volumen" => "157" "paginaInicial" => "1" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17609395" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor interacting protein gene mutations" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ M Georgitsi \n \t\t\t\t\t\t\t\t """ 1 => """ A Raitila \n \t\t\t\t\t\t\t\t """ 2 => """ A Karhu \n \t\t\t\t\t\t\t\t """ 3 => """ K Tuppurainen \n \t\t\t\t\t\t\t\t """ 4 => """ MJ Makinen \n \t\t\t\t\t\t\t\t """ 5 => """ O Vierimaa \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1073/pnas.0700004104" "Revista" => array:6 [ "tituloSerie" => "Proc Natl Acad Sci USA" "fecha" => "2007" "volumen" => "104" "paginaInicial" => "4101" "paginaFinal" => "4105" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17360484" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ GB Bolger \n \t\t\t\t\t\t\t\t """ 1 => """ AH Peden \n \t\t\t\t\t\t\t\t """ 2 => """ MR Steele \n \t\t\t\t\t\t\t\t """ 3 => """ C MacKenzie \n \t\t\t\t\t\t\t\t """ 4 => """ DG McEwan \n \t\t\t\t\t\t\t\t """ 5 => """ DA Wallace \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Biol Chem" "fecha" => "2003" "volumen" => "278" "paginaInicial" => "3351" "paginaFinal" => "3363" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => """ SK de Oliveira \n \t\t\t\t\t\t\t\t """ 1 => """ M Hoffmeister \n \t\t\t\t\t\t\t\t """ 2 => """ S Gambaryan \n \t\t\t\t\t\t\t\t """ 3 => """ W Muller-Esterl \n \t\t\t\t\t\t\t\t """ 4 => """ JA Guimaraes \n \t\t\t\t\t\t\t\t """ 5 => """ AP Smolenski \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1074/jbc.M610942200" "Revista" => array:6 [ "tituloSerie" => "J Biol Chem" "fecha" => "2007" "volumen" => "282" "paginaInicial" => "13656" "paginaFinal" => "13663" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17329248" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mutations of the BRAF gene in human cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ H Davies \n \t\t\t\t\t\t\t\t """ 1 => """ GR Bignell \n \t\t\t\t\t\t\t\t """ 2 => """ C Cox \n \t\t\t\t\t\t\t\t """ 3 => """ P Stephens \n \t\t\t\t\t\t\t\t """ 4 => """ S Edkins \n \t\t\t\t\t\t\t\t """ 5 => """ S Clegg \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nature00766" "Revista" => array:6 [ "tituloSerie" => "Nature" "fecha" => "2002" "volumen" => "417" "paginaInicial" => "949" "paginaFinal" => "954" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12068308" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ L Groussin \n \t\t\t\t\t\t\t\t """ 1 => """ LS Kirschner \n \t\t\t\t\t\t\t\t """ 2 => """ C Vincent-Dejean \n \t\t\t\t\t\t\t\t """ 3 => """ K Perlemoine \n \t\t\t\t\t\t\t\t """ 4 => """ E Jullian \n \t\t\t\t\t\t\t\t """ 5 => """ B Delemer \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/344579" "Revista" => array:6 [ "tituloSerie" => "Am J Hum Genet" "fecha" => "2002" "volumen" => "71" "paginaInicial" => "1433" "paginaFinal" => "1442" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12424709" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A meiotic recombination in a new isolated familial somatotropinoma kindred" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ DC Luccio-Camelo \n \t\t\t\t\t\t\t\t """ 1 => """ KN Une \n \t\t\t\t\t\t\t\t """ 2 => """ RE Ferreira \n \t\t\t\t\t\t\t\t """ 3 => """ SK Khoo \n \t\t\t\t\t\t\t\t """ 4 => """ R Nickolov \n \t\t\t\t\t\t\t\t """ 5 => """ MD Bronstein \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1530/eje.0.1500643" "Revista" => array:6 [ "tituloSerie" => "Eur J Endocrinol" "fecha" => "2004" "volumen" => "150" "paginaInicial" => "643" "paginaFinal" => "648" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15132719" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High penetrance of pheochromocytoma associated with the novel C634Y/Y791F double germline mutation in the RET protooncogene" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ RA Toledo \n \t\t\t\t\t\t\t\t """ 1 => """ SM Wagner \n \t\t\t\t\t\t\t\t """ 2 => """ FL Coutinho \n \t\t\t\t\t\t\t\t """ 3 => """ DM Lourenço Jr \n \t\t\t\t\t\t\t\t """ 4 => """ JA Azevedo \n \t\t\t\t\t\t\t\t """ 5 => """ VC Longuini \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2009-1355" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2010" "volumen" => "95" "paginaInicial" => "1318" "paginaFinal" => "1327" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20080836" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ DM Lourenço Jr \n \t\t\t\t\t\t\t\t """ 1 => """ RA Toledo \n \t\t\t\t\t\t\t\t """ 2 => """ II Mackowiak \n \t\t\t\t\t\t\t\t """ 3 => """ FL Coutinho \n \t\t\t\t\t\t\t\t """ 4 => """ MG Cavalcanti \n \t\t\t\t\t\t\t\t """ 5 => """ JE Correia-Deur \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1530/EJE-08-0153" "Revista" => array:6 [ "tituloSerie" => "Eur J Endocrinol" "fecha" => "2008" "volumen" => "159" "paginaInicial" => "259" "paginaFinal" => "274" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18524795" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Study of the multiple endocrine neoplasia type 1, growth hormone-releasing hormone receptor, Gs alpha, and Gi2 alpha genes in isolated familial acromegaly" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ BH Jorge \n \t\t\t\t\t\t\t\t """ 1 => """ SK Agarwal \n \t\t\t\t\t\t\t\t """ 2 => """ VS Lando \n \t\t\t\t\t\t\t\t """ 3 => """ R Salvatori \n \t\t\t\t\t\t\t\t """ 4 => """ RR Barbero \n \t\t\t\t\t\t\t\t """ 5 => """ N Abelin \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jcem.86.2.7218" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2001" "volumen" => "86" "paginaInicial" => "542" "paginaFinal" => "544" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11158006" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ DM Lourenço Jr \n \t\t\t\t\t\t\t\t """ 1 => """ RA Toledo \n \t\t\t\t\t\t\t\t """ 2 => """ FL Coutinho \n \t\t\t\t\t\t\t\t """ 3 => """ LC Margarido \n \t\t\t\t\t\t\t\t """ 4 => """ SA Siqueira \n \t\t\t\t\t\t\t\t """ 5 => """ MA dos Santos \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clinics" "fecha" => "2007" "volumen" => "62" "paginaInicial" => "465" "paginaFinal" => "476" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17823710" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ RA Toledo \n \t\t\t\t\t\t\t\t """ 1 => """ DM Lourenco \n \t\t\t\t\t\t\t\t """ 2 => """ FL Coutinho \n \t\t\t\t\t\t\t\t """ 3 => """ E Quedas \n \t\t\t\t\t\t\t\t """ 4 => """ I Mackowiack \n \t\t\t\t\t\t\t\t """ 5 => """ MC Machado \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Endocrinol" "fecha" => "2007" "volumen" => "67" "paginaInicial" => "377" "paginaFinal" => "384" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genetic screening of multiple endocrine neoplasia type 2: experience of the USP Endocrine Genetics Unit" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ MA Santos \n \t\t\t\t\t\t\t\t """ 1 => """ AB Nunes \n \t\t\t\t\t\t\t\t """ 2 => """ N Abelin \n \t\t\t\t\t\t\t\t """ 3 => """ MC Ezabella \n \t\t\t\t\t\t\t\t """ 4 => """ A Toledo Rde \n \t\t\t\t\t\t\t\t """ 5 => """ DM Lourenço Jr \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s0004-27302006000100003" "Revista" => array:6 [ "tituloSerie" => "Arq Bras Endocrinol Metabol" "fecha" => "2006" "volumen" => "50" "paginaInicial" => "7" "paginaFinal" => "16" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16628270" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of RET protooncogene analysis on the clinical management of multiple endocrine neoplasia type 2" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => """ SP Toledo \n \t\t\t\t\t\t\t\t """ 1 => """ MA dos Santos \n \t\t\t\t\t\t\t\t """ 2 => """ RA Toledo \n \t\t\t\t\t\t\t\t """ 3 => """ DM Lourenço Jr \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clinics" "fecha" => "2006" "volumen" => "61" "paginaInicial" => "59" "paginaFinal" => "70" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16532227" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A novel Val648Ile substitution in RET protooncogene observed in a Cys634Arg multiple endocrine neoplasia type 2A kindred presenting with an adrenocorticotropin-producing pheochromocytoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ AB Nunes \n \t\t\t\t\t\t\t\t """ 1 => """ MC Ezabella \n \t\t\t\t\t\t\t\t """ 2 => """ AC Pereira \n \t\t\t\t\t\t\t\t """ 3 => """ JE Krieger \n \t\t\t\t\t\t\t\t """ 4 => """ SP Toledo \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2002-020345" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2002" "volumen" => "87" "paginaInicial" => "5658" "paginaFinal" => "5661" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12466368" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ AC Latronico \n \t\t\t\t\t\t\t\t """ 1 => """ EM Pinto \n \t\t\t\t\t\t\t\t """ 2 => """ S Domenice \n \t\t\t\t\t\t\t\t """ 3 => """ MC Fragoso \n \t\t\t\t\t\t\t\t """ 4 => """ RM Martin \n \t\t\t\t\t\t\t\t """ 5 => """ MC Zerbini \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jcem.86.10.7957" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2001" "volumen" => "86" "paginaInicial" => "4970" "paginaFinal" => "4973" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11600572" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => """ KJ Livak \n \t\t\t\t\t\t\t\t """ 1 => """ TD Schmittgen \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1006/meth.2001.1262" "Revista" => array:6 [ "tituloSerie" => "Methods" "fecha" => "2001" "volumen" => "25" "paginaInicial" => "402" "paginaFinal" => "408" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11846609" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aryl hydrocarbon (Ah) receptor levels are selectively modulated by hsp90-associated immunophilin homolog XAP2" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => """ BK Meyer \n \t\t\t\t\t\t\t\t """ 1 => """ JR Petrulis \n \t\t\t\t\t\t\t\t """ 2 => """ GH Perdew \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1379/1466-1268(2000)005<0243:aharla>2.0.co;2" "Revista" => array:6 [ "tituloSerie" => "Cell Stress Chaperones" "fecha" => "2000" "volumen" => "5" "paginaInicial" => "243" "paginaFinal" => "254" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11005382" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ CA Leontiou \n \t\t\t\t\t\t\t\t """ 1 => """ M Gueorguiev \n \t\t\t\t\t\t\t\t """ 2 => """ J van der Spuy \n \t\t\t\t\t\t\t\t """ 3 => """ R Quinton \n \t\t\t\t\t\t\t\t """ 4 => """ F Lolli \n \t\t\t\t\t\t\t\t """ 5 => """ S Hassan \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2007-2611" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2008" "volumen" => "93" "paginaInicial" => "2390" "paginaFinal" => "2401" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18381572" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumors" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => """ CA Landis \n \t\t\t\t\t\t\t\t """ 1 => """ SB Masters \n \t\t\t\t\t\t\t\t """ 2 => """ A Spada \n \t\t\t\t\t\t\t\t """ 3 => """ AM Pace \n \t\t\t\t\t\t\t\t """ 4 => """ HR Bourne \n \t\t\t\t\t\t\t\t """ 5 => """ L Vallar \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/340692a0" "Revista" => array:6 [ "tituloSerie" => "Nature" "fecha" => "1989" "volumen" => "340" "paginaInicial" => "692" "paginaFinal" => "696" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2549426" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib30" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ LS Kirschner \n \t\t\t\t\t\t\t\t """ 1 => """ JA Carney \n \t\t\t\t\t\t\t\t """ 2 => """ SD Pack \n \t\t\t\t\t\t\t\t """ 3 => """ SE Taymans \n \t\t\t\t\t\t\t\t """ 4 => """ C Giatzakis \n \t\t\t\t\t\t\t\t """ 5 => """ YS Cho \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/79238" "Revista" => array:6 [ "tituloSerie" => "Nature Genetics" "fecha" => "2000" "volumen" => "26" "paginaInicial" => "89" "paginaFinal" => "92" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10973256" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib31" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A genomewide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:5 [ 0 => """ A Horvath \n \t\t\t\t\t\t\t\t """ 1 => """ S Boikos \n \t\t\t\t\t\t\t\t """ 2 => """ C Giatzakis \n \t\t\t\t\t\t\t\t """ 3 => """ A Robinson-White \n \t\t\t\t\t\t\t\t """ 4 => """ L Groussin \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ng1809" "Revista" => array:6 [ "tituloSerie" => "Nat Genet" "fecha" => "2006" "volumen" => "38" "paginaInicial" => "794" "paginaFinal" => "800" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16767104" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib32" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mutation in PDE8B, a cyclic AMPspecific phosphodiesterase in adrenal hyperplasia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => """ A Horvath \n \t\t\t\t\t\t\t\t """ 1 => """ V Mericq \n \t\t\t\t\t\t\t\t """ 2 => """ CA Stratakis \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2008" "volumen" => "358" "paginaInicial" => "750" "paginaFinal" => "752" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18283725" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib33" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ M Kjellman \n \t\t\t\t\t\t\t\t """ 1 => """ L Roshani \n \t\t\t\t\t\t\t\t """ 2 => """ BT Teh \n \t\t\t\t\t\t\t\t """ 3 => """ OP Kallioniemi \n \t\t\t\t\t\t\t\t """ 4 => """ A Höög \n \t\t\t\t\t\t\t\t """ 5 => """ S Gray \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jcem.84.2.5506" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "1999" "volumen" => "84" "paginaInicial" => "730" "paginaFinal" => "735" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10022445" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib34" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MEN1 gene analysis in sporadic adrenocortical neoplasms" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ C Heppner \n \t\t\t\t\t\t\t\t """ 1 => """ M Reincke \n \t\t\t\t\t\t\t\t """ 2 => """ SK Agarwal \n \t\t\t\t\t\t\t\t """ 3 => """ P Mora \n \t\t\t\t\t\t\t\t """ 4 => """ B Allolio \n \t\t\t\t\t\t\t\t """ 5 => """ AL Burns \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jcem.84.1.5388" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "1999" "volumen" => "84" "paginaInicial" => "216" "paginaFinal" => "219" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9920087" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib35" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adrenocortical carcinoma: clinical and laboratory observations" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ BL Wajchenberg \n \t\t\t\t\t\t\t\t """ 1 => """ MA Albergaria Pereira \n \t\t\t\t\t\t\t\t """ 2 => """ BB Medonca \n \t\t\t\t\t\t\t\t """ 3 => """ AC Latronico \n \t\t\t\t\t\t\t\t """ 4 => """ P Campos Carneiro \n \t\t\t\t\t\t\t\t """ 5 => """ VA Alves \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "2000" "volumen" => "88" "paginaInicial" => "711" "paginaFinal" => "736" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10679640" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/18075932/0000006500000004/v1_202212011714/S1807593222024565/v1_202212011714/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/18075932/0000006500000004/v1_202212011714/S1807593222024565/v1_202212011714/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1807593222024565?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 0 | 4 |
2024 October | 23 | 18 | 41 |
2024 September | 24 | 11 | 35 |
2024 August | 27 | 12 | 39 |
2024 July | 22 | 17 | 39 |
2024 June | 14 | 5 | 19 |
2024 May | 13 | 11 | 24 |
2024 April | 13 | 11 | 24 |
2024 March | 11 | 13 | 24 |
2024 February | 8 | 10 | 18 |
2024 January | 7 | 7 | 14 |
2023 December | 6 | 14 | 20 |
2023 November | 10 | 20 | 30 |
2023 October | 7 | 21 | 28 |
2023 September | 10 | 16 | 26 |
2023 August | 8 | 12 | 20 |
2023 July | 10 | 11 | 21 |
2023 June | 10 | 9 | 19 |
2023 May | 25 | 0 | 25 |
2023 April | 36 | 1 | 37 |
2023 March | 19 | 1 | 20 |
2023 February | 6 | 1 | 7 |
2023 January | 1 | 1 | 2 |
2022 December | 7 | 3 | 10 |